ESR1 and ovarian endometrioid adenocarcinoma: Jin et al. [127] identified the downregulation of estrogen receptor 1 (ER1) in ovarian cancer cells upon treatment with bile acids, suggesting a therapeutic effect, given that upregulated ER is positively associated with peritoneal metastasis in endometrioid ovarian cancer [128].